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1. Introduction 
We have recently shown that chymotrypsin-like 
serine proteases, which exist in an enzymatically 
active form on the cell surface membrane, are involved 
in the superoxide (0;) production by human poly- 
morphonuclear leukocytes @‘MN) and monocytes 
stimulated by cytochalasin E and concanavalin A 
[ 121. To clarify the role of the serine proteases, we 
investigate here whether the same serine proteases are 
also involved in the Oi- production induced by other 
soluble agents, including wheat germ agglutinin (a 
lectin), N-formylmethionyl phenylalanine (a chemo- 
tactic peptide), phorbol myristate acetate (an active 
principle of croton oil), calcium ionophore A23 187 
and phospholipase C, which appear to initiate the 
oxidative metabolism of phagocytic cells through 
different mechanisms [3-l 11. The O;- production by 
human PMN and monocytes stimulated by these 
active agents was also inhibited by irreversible serine 
protease inhibitors and synthetic substrates for serine 
proteaseqindicating that the serine proteases are essen- 
tial for human PMN and monocytes to release O;-. 
Abbreviations: PMN, polymorphonuclear leukocytes; Hepes, 
N-2hydroxyethylpiperazine-N ‘-2ethane-sulfonic acid; SOD, 
superoxide dismutase; FMP, N-formylmethionyl phenylalanine; 
PMA, phorbol myristate acetate; WGA, wheat germ agglutinin; 
PMSF, phenylmethylsulfonylfluoride; TPCK, L-l-tosylamido- 
2-phenylethyl-chloromethyl ketone; TLCK, N-o-p-tosyl- 
L-lysinechloromethyl ketone; BTEE, N-benzoyl-L-tyrosine 
ethyl ester; TAME, p-tosyl-Larginine methyl ester 
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2. Materials and methods 
Cytochrome c type VI, superoxide dismutase, 
N-formylmethionyl phenylalanine, phorbol myristate 
acetate, phospholipase C, phenylmethylsulfonyl- 
fluoride, L-l -tosylamido-2-phenylethyl-chloromethyl 
ketone+o-p-tosyl-L-lysine chloromethyl ketone, 
N-benzoyl-L-tyrosine ethyl ester and p-tosyl-l-argi- 
nine methyl ester were purchased from Sigma Chem- 
ical Co., St Louis, MO; wheat germ agglutinin (WGA) 
from EY Labs., San Mateo, CA; calcium ionophore 
A23187 was a gift from Dr R. J. Hosley, Eli Lilly Co., 
Indianapolis, IN. PMSF, TPCK, BTEE, FMP, PMA 
and A23187 were dissolved in dimethylsulfoxide and 
diluted with Hepes-saline (isotonic saline solution 
buffered with 5 mM N-2-hydroxyethyl-piperazine- 
N’-2ethane sulfonic acid,pH 7.4) immediately before 
use. The final concentration of DMSO in the reaction 
mixture was < 5 pi/ml and the same concentration of 
DMSO was added in the controls. 
2.1. Preparation of cells 
PMN and mononuclear cell preparations were 
obtained from healthy adult donors by the dextran 
sedimentation and Conray-Ficoll method as in [ 1,2]. 
Both cell preparations were suspended in Hepes- 
saline. PMN preparations contained > 99% PMN. 
Mononuclear cell fractions were used as monocyte 
fractions, which contained 15-25% monocytes and 
< 1% PMN by morphological criteria. The rest was 
composed of lymphocytes. Monocytes are considered 
to be responsible for the O,- production by mono- 
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nuclear cells, since the O;- production by non-phago- 
cytic cells 0 99% lymphocytes) is negligible when 
phagocytic cells ingesting carbonyl iron particles are 
eliminated by a magnet from the mononuclear cell 
fractions [ 21. 
2.2. Determination of PMN and monocyte O;- pro- 
duction 
O;- was assayed by SOD-inhibitable cytochrome c 
reduction spectrophotometrically, using a Hitachi 557 
spectrophotometer (a double wavelength spectro- 
photometer with end-on photomultiplier) as in [ 11. 
The cell suspension was added to a 1 ml cuvette con- 
taining 2 mM glucose, 1 mM CaClz and 66 PM ferri- 
cytochrome c with or without test materials to obtain 
0.99-0.995 ml final vol. The reaction mixture in the 
cuvette was preincubated at 37’C for 3 min for pro- 
tease inhibitors and for 10 min for synthetic sub- 
strates of serine proteases, respectively. The cuvette 
was put into the thermostated cuvette holder (37’C) 
of a spectrophotometer and the reduction of cyto- 
chrome c was measured at 550 nm with a reference 
wavelength at 540 nm. Various stimulating agents 
(5 - 10 ~1) were added to the reaction mixtures in 
cuvettes to obtain 1 ml final vol. and the desired 
f 1 M 
cytochromr 
1 
concentrations of these agents. Final cell concentra- 
tions were variable in accordance with the potencies 
of the active agents. In PMN O;- production studies, 
4-8 X lO’/ml were used for PMA; l-3 X lO”/ml for 
WGA, FMP and A23187; and 1 X lO’/ml for phos- 
pholipase C, respectively. In monocyte O;- produc- 
tion studies, l-3 X 1 O6 mononuclear cells/ml were 
used for WGA, PMA and FMP. In these studies, cell 
viability by the erythrosine B dye-exclusion test was 
always checked after the assay of O;- production 
and was > 95%. 
3. Results and discussion 
WGA, FMP, PMA, A23187 and phospholipase C 
were able to stimulate human PMN and monocytes to 
release O;- (fig.1) [3-l 11, however A23187 and 
phosphohpase C were toxic for mononuclear cells 
but not for PMN at the concentrations used in the 
present experiments. Therefore, A23 187 and phos- 
pholipase C were excluded from the monocyte O;- 
production studies. The representative time courses 
of PMN O;- production are shown in fig.1. The 
almost similar patterns were observed in monocyte 
Fig.1. O;- production by human PMN stimulated by various active agents. Cell concentrations u ed were 8 X lO’/ml for PMA, 
1 X lO’/ml for phospholipase C and 2 X 106/ml for FMP, A23187 and WGA. 
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O;- production (data not shown). Cytochrome c
reduction induced by these active agents was com- 
pletely abolished by SOD (20 /_tg/ml) suggesting it 
to be specific for O;-. The O;- production by human 
PMN and monocytes was calculated from an appar- 
ently linear portion in PMA and phospholipase C 
induced O;- production [ 11, and was calculated from 
cytochrome c reduced for 2 mm after the addition 
of FMP or A23 187 and for 5 min after the addition 
of WGA (fig.1). The values of cytochrome c reduced 
in the resting states were subtracted from those in 
the stimulated states. 
As shown in table 1, irreversible serine protease 
inhibitors (PMSF, TPCK and TLCK) and synthetic 
substrates for serine proteases (BTEE and TAME) 
inhibited the O;- production by human PMN and 
monocytes induced by several active agents, includ- 
ing WGA, FMP, PMA, A23 187 and phospholipase C,
the actions of which are suggested to be different 
from one another. WGA binds to @(l-+4)-D-ZV- 
acetylglucosamine), onthe cell surface membrane 
[ 121. FMP and PMA are also suggested to bind to 
the cell surface membrane [ 13,141, although it is 
uncertain what molecules are the binding sites. It is 
probable that membrane perturbation provoked by 
the binding of these active agents on the cell surface 
membrane isresponsible for the O;- production. On 
the other hand, phospholipase C acts on the mem- 
brane lipid and hydrolyzes phosphatidylcholine 
[ 111, which is a major component of the outer layer 
of the cell membrane. It is unknown how phospho- 
lipase C is able to provoke the oxidative metabolism, 
while it is possible that the hydrolysis of phospha- 
tidylcholine results in the conformational changes 
of the membrane and allows the redistribution of 
the macromolecules onthe surface membrane, which 
in turn activates the NAD(P)H oxidase. A23 187 is 
suggested to initiate the oxidative metabolism by 
promoting Cap influx from the milieu [B]. It has 
been reported that extracellular Cap plays an impor- 
tant-role and enhances the oxidative metabolism 
induced by IV-formylmethionyl peptides and phos- 
Table 1 
Inhibitory effect of serine protease inhibitors and synthetic substrates for serine proteases 
on PMN and monocyte O;- production induced by various surface active agents 
PMN O;- production (% control)a 
WGA FMP PMA A23187 phospholipase C 
(100 rg/mD (20 rM) (20 ng/ml) (10 fiuM) (0.25 units/ml) 
PMSF (1 mM) 34.5 f 7.3 23.2 + 5.5 82.6 * 2.1 14.5 f 2.8 n.d. 
TPCK (10 PM) 27.0 f 1.4 31.2* 6.3 50.9 k 1.4 22.5 f 8.7 11.1 * 3.2 
TLCK (100 /JM) 49.1 f 5.8 46.7 f 1.6 74.4 f 1.4 64.4 f 4.0 20.4 i 2.6 
BTEE (SOpM) n.d. 27.0 * 4.2 77.8 f 4.5 n.d. n.d. 
TAME (1 mM) n.d. 79.8 f 9.0 82.1 f 2.8 n.d. n.d. 
Monocyte O;- production (% controDa 
WGA FMP 
(100 pgg/mD (20 /JM) 
PMSF (1 mM) 50.8 * 3.9 
TPCK (10 MM) 27.3 f 2.9 
TLCK (100 /JM) 60.4 f 3.6 
BTEE (50 PM) n.d. 
TAME (1 mM) n.d. 
54.7 i 6.4 
67.6 f 1.5 
63.9 f 6.6 
23.2 i 5.6 
69.1 f 3.3 
PMA 
(20 ng/mD 
68.5 f 5.4 
52.4 f 8.8 
65.1 * 3.3 
69.3 f 7.4 
88.6 f 7.9 
a Mean f SD. Average of 2 or 3 experiments; each experiment was done in duplicate 
n.d., not done 
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0; release ( % control 1 protease inhibitors and synthetic substrates for 
serine proteases are able to inhibit the O;- produc- 
tion by human PMN and monocytes induced by 
various surface active agents, indicating that the 
serine proteases play an essential role for the O;- 
production by human PMN and monocytes. 
100 
80 
60 
3 
- 
F% Cd+ 1 mM rc_9’ cc-5*+ 
TkK 
10uM 
Fig.2. Effect of extracelhrlar Ca” and TPCK on PMN O;- 
production induced by WGA. WGA (100 rg/ml) was added 
to the reaction mixture containing 1 mM Ca* or no Ca* with 
or without TPCK (10 PM). The value of O;- produced in the 
condition containing 1 mM Cal+ without TPCK is shown as 
100% control. Bars denote mean * SD. 
pholipase C [3-5,111, while PMA-induced O;- pro- 
duction is never affected by extracellular Ca2+ [5]. 
As shown in fig.2, WGA-induced O;- production by 
human PMN was also enhanced by extracellular Ca2+, 
and it was inhibited by TPCK whether Ca2+ was 
present in the milieu or not. These above findings 
indicate that the serine proteases may not be impli- 
cated in Ca2+ influx. Differences of the inhibition 
were seen when different stimulants were used 
(table 1). This may be partly explained by the dif- 
ferences of the actions among the stimulants. 
The present experiments have shown that serine 
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